Cargando…
Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
Autores principales: | Genest, Dominique S., Pelletier, Karyne, Dallaire, Gabriel, Faucher, Geneviève, Troyanov, Stéphan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938147/ https://www.ncbi.nlm.nih.gov/pubmed/33733004 http://dx.doi.org/10.1016/j.ekir.2021.01.033 |
Ejemplares similares
-
Persistent Mixed Cryoglobulinemia Despite Successful Treatment of Hepatitis C, Aggressive B-Cell–Directed Therapies, and Long-term Plasma Exchanges
por: Pelletier, Karyne, et al.
Publicado: (2019) -
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022) -
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022) -
Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021) -
Mixed cryoglobulinemia
por: Ferri, Clodoveo
Publicado: (2008)